Who to call at Gilead Sciences, and when
Fundz watches for the moments Gilead Sciences starts buying, and tells you who to reach.
- An alert the day Gilead Sciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Gilead Sciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gilead Sciences. With Fundz connected, it knows.
Gilead and PAHO Forge Partnership to Enhance Access to Lenacapavir for HIV Prevention in Latin America and the Caribbean.
Contract Type
partnership
Description
Gilead Sciences has announced a new partnership with the Pan American Health Organization to improve access to twice-yearly lenacapavir for HIV prevention. This agreement establishes a regional pathway that supports country-led efforts in Latin America and the Caribbean to adopt long-acting HIV prevention methods.
Other recent agreements in Therapeutics and Biopharma
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- YD Bio and EG BioMed Form Partnership with JoiiUp to Launch AI Cancer Risk Assessment for Corporate Wellness. (October 20, 2026)
- Hansoh Pharma and Roche Expand Partnership with $15 Billion Agreement for ADC Programs. (October 19, 2026)
- NUCLIDIUM and NorthStar Forge Long-term Strategic Partnership to Enhance Copper-67 Radiotheranostic Oncology Pipeline. (October 19, 2026)
- Prothena Partners with Roche to Advance Prasinezumab for Parkinson's Disease Treatment. (October 20, 2026)
- DARPA Awards Up to $10.7 Million Contract to RxMP Therapeutics for Development of RMP-402. (October 20, 2026)
- Genmab and Incyte collaborate on a colorectal cancer trial using petosemtamab and a mutation-targeting drug. (October 24, 2026)
Related People
Agreement Insights
What this usually meansGilead Sciences signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.